Anti-inflammatory treatments for stroke: from bench to bedside

被引:69
|
作者
Drieu, Antoine [1 ]
Levard, Damien [1 ]
Vivien, Denis [1 ,2 ]
Rubio, Marina [1 ]
机构
[1] Normandy Univ, Pathophysiol & Imaging Neurol Disorders, Blvd Henri Becquerel BP 5229, F-14000 Caen, France
[2] CHU Caen, Imaging Neurol Disorders, Caen, France
关键词
clinical trial; immunomodulatory drugs; inflammation; stroke models; translation; ACUTE ISCHEMIC-STROKE; REGULATORY T-CELLS; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; IMMUNE MODULATOR FINGOLIMOD; SENSITIVE MOLECULAR MRI; CENTRAL-NERVOUS-SYSTEM; REDUCES BRAIN-DAMAGE; THROMBOEMBOLIC STROKE;
D O I
10.1177/1756286418789854
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
So far, intravenous tissue-type plasminogen activator (tPA) and mechanical removal of arterial blood clot (thrombectomy) are the only available treatments for acute ischemic stroke. However, the short therapeutic window and the lack of specialized stroke unit care make the overall availability of both treatments limited. Additional agents to combine with tPA administration or thrombectomy to enhance efficacy and improve outcomes associated with stroke are needed. Stroke-induced inflammatory processes are a response to the tissue damage due to the absence of blood supply but have been proposed also as key contributors to all the stages of the ischemic stroke pathophysiology. Despite promising results in experimental studies, inflammation-modulating treatments have not yet been translated successfully into the clinical setting. This review will (a) describe the timing of the stroke immune pathophysiology; (b) detail the immune responses to stroke sift-through cell type; and (c) discuss the pitfalls on the translation from experimental studies to clinical trials testing the therapeutic pertinence of immune modulators.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Anti-Inflammatory Effects of Vinpocetine in Atherosclerosis and Ischemic Stroke: A Review of the Literature
    Zhang, Linjie
    Yang, Li
    MOLECULES, 2015, 20 (01): : 335 - 347
  • [22] Inflammatory biomarkers and coronary heart disease: from bench to bedside and back
    Gina Biasillo
    Milena Leo
    Roberta Della Bona
    Luigi Marzio Biasucci
    Internal and Emergency Medicine, 2010, 5 : 225 - 233
  • [23] Inflammatory biomarkers and coronary heart disease: from bench to bedside and back
    Biasillo, Gina
    Leo, Milena
    Della Bona, Roberta
    Biasucci, Luigi Marzio
    INTERNAL AND EMERGENCY MEDICINE, 2010, 5 (03) : 225 - 233
  • [24] Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside—a Comprehensive Review
    C. Henrique Alves
    Eric Farrell
    Marijn Vis
    Edgar M. Colin
    Erik Lubberts
    Clinical Reviews in Allergy & Immunology, 2016, 51 : 27 - 47
  • [25] Therapeutic potential of anti-inflammatory drugs in focal stroke
    Barone, FC
    Parsons, AA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (10) : 2281 - 2306
  • [26] Anti-inflammatory Strategies in Stroke: A Potential Therapeutic Target
    Siniscalchi, Antonio
    Iannacchero, Rosario
    Anticoli, Sabrina
    Pezzella, Francesca Romana
    De Sarro, Giovambattista
    Gallelli, Luca
    CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (01) : 98 - 105
  • [27] Anti-Inflammatory Treatments during the Chronic Phase of Spinal Cord Injury Improve Locomotor Function in Adult Mice
    Arnold, Sheila A.
    Hagg, Theo
    JOURNAL OF NEUROTRAUMA, 2011, 28 (09) : 1995 - 2002
  • [28] Resveratrol in Cancer Patients: From Bench to Bedside
    Berretta, Massimiliano
    Bignucolo, Alessia
    Di Francia, Raffaele
    Comello, Francesco
    Facchini, Gaetano
    Ceccarelli, Manuela
    Iaffaioli, Rosario Vincenzo
    Quagliariello, Vincenzo
    Maurea, Nicola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [29] Anti-Inflammatory Effects of ADAMTS-4 in a Mouse Model of Ischemic Stroke
    Lemarchant, Sighild
    Dunghana, Hiramani
    Pomeshchik, Yuriy
    Leinonen, Henri
    Kolosowska, Natalia
    Korhonen, Paula
    Kanninen, Katja M.
    Garcia-Berrocoso, Teresa
    Montaner, Joan
    Malm, Tarja
    Koistinaho, Jari
    GLIA, 2016, 64 (09) : 1492 - 1507
  • [30] Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts
    Cazzola, Mario
    Calzetta, Luigino
    Rogliani, Paola
    Matera, Maria Gabriella
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 2481 - 2495